Category: Professional Posters
Purpose: Hamad Medical Corporation (HMC) postgraduate year one (PGY1) pharmacy residency program is the first American Society of Health-System Pharmacists (ASHP) accredited program in Qatar and among few accredited programs outside United States (US). HMC is the leading provider of secondary and tertiary healthcare in Qatar and the only healthcare system outside the US to have all of its hospitals accredited by Joint Commission International (JCI). Developing a pharmacy residency program and attaining ASHP accreditation is considered a cornerstone in the pharmacy profession advancement in Qatar.
A team of executive director of pharmacy, residency program director (RPD), residency program coordinators and pharmacists representing HMC hospitals was appointed as the residency advisory committee (RAC) to lead the program establishment and development. The RAC established a firm selection process of residency preceptors and residents; designed the learning experiences curriculum, monitored the program progress, and arranged the accreditation procedures. The ASHP accreditation survey report went through extensive reviews on regular meetings by the residency team to prepare for the program’s official response report. The program applied a rigorous process to ensure compliance with 2014 ASHP accreditation standards.
Results: The first recruitment was in 2015 summer, and the first patch of two residents started a twelve months residency program with an ASHP accreditation candidate status. The ASHP surveyors were hosted on October 2016 seeking full residency program accreditation. The survey schedule included visits to different HMC facilities that are integrated with the corporate pharmacy department besides meeting the residency team. The ASHP accreditation survey report was received on Jan 2017 and did not include any areas of noncompliance to the accreditations’ standards. The program’s survey response report covered areas of partial compliance findings the majority of which have been involved in the residency program development and advancement and incorporated within pharmacy department strategic plans. Few remaining challenging areas for partial compliance were related to different HMC corporate levels have been worked up through various meetings and committees. Moreover, ASHP survey response incorporated consultative recommendations that inspired our residency program to go beyond the accreditation standards and go extra miles in getting the most out of this program. The official accreditation was received in April 2017 for three years (2017-2020).
Conclusion: HMC PGY1 pharmacy residency program successfully achieved ASHP accreditation in two years and created an opportunity to foster Qatar’s pharmacy practice. Such international accreditation assures that the advanced training will provide our pharmacists with the knowledge, skills, and experience they need to excel in their careers, which will further enhance pharmacy clinical practices and the quality of patients care. The program is considering plans for pursuing a PGY2 program establishment and its accreditation.